Six-month results from a Phase III randomized trial of fixed-combination brinzolamide 1% + brimonidine 0.2% versus brinzolamide or brimonidine monotherapy in glaucoma or ocular hypertension

BACKGROUND: The objective of this study was to examine the safety and intraocular pressure (IOP)-lowering efficacy of a fixed combination of brinzolamide 1% + brimonidine 0.2% (BBFC) after six months of treatment in patients with open-angle glaucoma or ocular hypertension. METHODS: This was a random...

Descripción completa

Detalles Bibliográficos
Autores principales: Whitson, Jess T, Realini, Tony, Nguyen, Quang H, McMenemy, Matthew G, Goode, Stephen M
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Dove Medical Press 2013
Materias:
Original Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678899/
https://www.ncbi.nlm.nih.gov/pubmed/23766627
http://dx.doi.org/10.2147/OPTH.S46881

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3678899/
https://www.ncbi.nlm.nih.gov/pubmed/23766627
http://dx.doi.org/10.2147/OPTH.S46881

Ejemplares similares